Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DU BOSPHORE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DU BOSPHORE is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARSEILLE (13015), this company of category PME shows in 2022 a revenue of 3.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DU BOSPHORE (SIREN 752406512)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C 3 600 938 € N/C N/C N/C N/C
Net income 96 800 € 111 988 € 195 022 € 271 977 € 149 165 € 136 278 € 155 923 € 180 708 €
EBITDA N/C N/C N/C 406 963 € N/C N/C N/C N/C
Net margin N/C N/C N/C 7.6% N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE DU BOSPHORE generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 181 k€ -> 97 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

96 800 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 312%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 21%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

312.05%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

21.203%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.0%

Solvency indicators evolution
SELARL PHARMACIE DU BOSPHORE

Sector positioning

Debt ratio
312.05 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average +9 pts over 3 years

In 2025, the debt ratio of SELARL PHARMACIE DU BOSPHORE (312.05) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
21.2% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch -11 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE DU BOSPHORE (21.2%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 129.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

129.339

Liquidity indicators evolution
SELARL PHARMACIE DU BOSPHORE

Sector positioning

Liquidity ratio
129.34 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Watch -13 pts over 3 years

In 2025, the liquidity ratio of SELARL PHARMACIE DU BOSPHORE (129.34) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 607 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 966 days. Excellent situation: suppliers finance 359 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

607 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

966 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DU BOSPHORE

Positioning of SELARL PHARMACIE DU BOSPHORE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE DU BOSPHORE is estimated at 1 537 679 € (range 1 043 476€ - 2 412 830€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1043k€ 1537k€ 2412k€
1 537 679 € Range: 1 043 476€ - 2 412 830€
NAF 5 année 2025

Valuation method used

Net Income Multiple
96 800 € × 15.9x = 1 537 680 €
Range: 1 043 477€ - 2 412 831€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DU BOSPHORE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DU BOSPHORE

What is the revenue of SELARL PHARMACIE DU BOSPHORE ?

The revenue of SELARL PHARMACIE DU BOSPHORE in 2022 is 3.6 M€.

Is SELARL PHARMACIE DU BOSPHORE profitable?

Yes, SELARL PHARMACIE DU BOSPHORE generated a net profit of 97 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE DU BOSPHORE ?

The headquarters of SELARL PHARMACIE DU BOSPHORE is located in MARSEILLE (13015), in the department Bouches-du-Rhone.

Where to find the tax return of SELARL PHARMACIE DU BOSPHORE ?

The tax return of SELARL PHARMACIE DU BOSPHORE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DU BOSPHORE operate?

SELARL PHARMACIE DU BOSPHORE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.